UBS Group’s Orgenesis Inc. Common Stock ORGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,743
| Closed | -$21.2K | – | 10720 |
|
|
2024
Q3 | $21.2K | Buy |
4,743
+4,116
| +656% | +$27.4K | ﹤0.01% | 7336 |
|
|
2024
Q2 | $3.76K | Buy |
+627
| New | +$3.29K | ﹤0.01% | 8175 |
|
|
2024
Q1 | – | Sell |
-110
| Closed | -$551 | – | 10217 |
|
|
2023
Q4 | $551 | Buy |
110
+103
| +1,471% | +$660 | ﹤0.01% | 8597 |
|
|
2023
Q3 | $42 | Sell |
7
-43
| -86% | -$385 | ﹤0.01% | 9036 |
|
|
2023
Q2 | $694 | Buy |
50
+34
| +213% | +$403 | ﹤0.01% | 8130 |
|
|
2023
Q1 | $190 | Sell |
16
-570
| -97% | -$10.7K | ﹤0.01% | 9147 |
|
|
2022
Q4 | $11.4K | Buy |
586
+292
| +99% | +$4.97K | ﹤0.01% | 8401 |
|
|
2022
Q3 | $4K | Sell |
294
-36
| -11% | -$677 | ﹤0.01% | 9425 |
|
|
2022
Q2 | $8K | Buy |
+330
| New | +$9.19K | ﹤0.01% | 8377 |
|
|
2022
Q1 | – | Sell |
-921
| Closed | -$27K | – | 11082 |
|
|
2021
Q4 | $27K | Buy |
+921
| New | +$36K | ﹤0.01% | 7513 |
|
|
2021
Q3 | – | Sell |
-83
| Closed | -$4.17K | – | 10235 |
|
|
2021
Q2 | $4K | Sell |
83
-416
| -83% | -$20.9K | ﹤0.01% | 8714 |
|
|
2021
Q1 | $29K | Buy |
499
+100
| +25% | +$6.51K | ﹤0.01% | 7046 |
|
|
2020
Q4 | $18K | Buy |
399
+254
| +175% | +$12.2K | ﹤0.01% | 7027 |
|
|
2020
Q3 | $7K | Sell |
145
-452
| -76% | -$24.5K | ﹤0.01% | 7153 |
|
|
2020
Q2 | $36K | Buy |
597
+531
| +805% | +$32.1K | ﹤0.01% | 6145 |
|
|
2020
Q1 | $2K | Sell |
66
-29
| -31% | -$1.27K | ﹤0.01% | 7662 |
|
|
2019
Q4 | $4K | Sell |
95
-234
| -71% | -$7.8K | ﹤0.01% | 7689 |
|
|
2019
Q3 | $14K | Buy |
329
+68
| +26% | +$3.04K | ﹤0.01% | 6964 |
|
|
2019
Q2 | $11K | Buy |
261
+155
| +146% | +$6.99K | ﹤0.01% | 7036 |
|
|
2019
Q1 | $6K | Sell |
106
-20
| -16% | -$998 | ﹤0.01% | 7109 |
|
|
2018
Q4 | $6K | Sell |
126
-516
| -80% | -$29.6K | ﹤0.01% | 7499 |
|
|
2018
Q3 | $35K | Buy |
642
+636
| +10,600% | +$43K | ﹤0.01% | 6436 |
|
|
2018
Q2 | $0 | Sell |
6
-43
| -88% | -$3.99K | ﹤0.01% | 8324 |
|
|
2018
Q1 | $6K | Buy |
+49
| New | +$5.8K | ﹤0.01% | 7172 |
|
UBS Group's ORGS Position: Q4 2024 in Review
UBS Group sold out of Orgenesis Inc. Common Stock (ORGS) in Q4 2024, closing a stake of 4,743 shares — an estimated $21.2K sold.
UBS Group first reported a position in ORGS in Q1 2018 and held it in 24 quarters. The position peaked at $36K in Q2 2020. 0 funds tracked by Wall St. Rank hold ORGS as of Q4 2024.
- UBS Group reported no remaining Orgenesis Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- UBS Group sold 4,743 Orgenesis Inc. Common Stock shares in Q4 2024, an estimated $21.2K.
- UBS Group first reported a position in Orgenesis Inc. Common Stock in Q1 2018 and held it in 24 quarters.
- UBS Group's Orgenesis Inc. Common Stock position peaked at $36K in Q2 2020.
- 0 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q4 2024.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.